litlas
Log inCreate account

Peter L. Collins

Active 1980–2025

161
Papers
23,309
Citations
96
h-index
156
i10-index

Citations

Citations per year for Peter L. Collins1981: 1 citations1982: 3 citations1983: 10 citations1984: 15 citations1985: 27 citations1986: 40 citations1987: 48 citations1988: 53 citations1989: 41 citations1990: 28 citations1991: 57 citations1992: 40 citations1993: 28 citations1994: 37 citations1995: 39 citations1996: 44 citations1997: 91 citations1998: 95 citations1999: 138 citations2000: 115 citations2001: 142 citations2002: 132 citations2003: 109 citations2004: 223 citations2005: 251 citations2006: 248 citations2007: 198 citations2008: 186 citations2009: 187 citations2010: 166 citations2011: 187 citations2012: 163 citations2013: 177 citations2014: 186 citations2015: 162 citations2016: 154 citations2017: 110 citations2018: 146 citations2019: 614 citations2020: 880 citations2021: 645 citations2022: 406 citations2023: 301 citations2024: 503 citations2025: 286 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,028 citing papers, 33% of this breakdownChina: 488 citing papers, 7.9% of this breakdownUnited Kingdom: 437 citing papers, 7.1% of this breakdownGermany: 288 citing papers, 4.7% of this breakdownFrance: 269 citing papers, 4.4% of this breakdownCanada: 205 citing papers, 3.3% of this breakdownJapan: 189 citing papers, 3.1% of this breakdownNetherlands: 164 citing papers, 2.7% of this breakdownAustralia: 159 citing papers, 2.6% of this breakdownItaly: 145 citing papers, 2.4% of this breakdownSpain: 137 citing papers, 2.2% of this breakdownSwitzerland: 113 citing papers, 1.8% of this breakdown
0%33%Other 24.8%

Institutions

Fields

  • Medicine81.3%
  • Biochemistry, Genetics and Molecular Biology7.8%
  • Immunology and Microbiology6.7%
  • Agricultural and Biological Sciences1.9%
  • Environmental Science0.6%
  • Neuroscience0.4%
  • Other1.3%

Topics

  • Respiratory viral infections research14.4%
  • Virology and Viral Diseases5.7%
  • Viral gastroenteritis research and epidemiology5.3%
  • SARS-CoV-2 and COVID-19 Research5.2%
  • Animal Virus Infections Studies4%
  • Viral Infections and Vectors4%
  • Other61.4%

Coauthors

All papers

Open in search
  1. ICTV Virus Taxonomy Profile: Pneumoviridae

    Authors: B. K. Rima, Peter L. Collins, Andrew J. Easton, Ron A. M. Fouchier, Gael Kurath, Robert A. Lamb, Benhur Lee, Andrea Maisner, Paul Rota, Lin‐Fa Wang - Journal of General Virology 2017 cited by 399

  2. Respiratory Syncytial Virus: Virology, Reverse Genetics, and Pathogenesis of Disease

    Authors: Peter L. Collins, Rachel Fearns, Barney S. Graham - Current topics in microbiology and immunology 2013 cited by 379

  3. Sorafenib in combination with transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma (TACE 2): a randomised placebo-controlled, double-blind, phase 3 trial

    Authors: Tim Meyer, Richard Fox, Yuk Ting, Paul J. Ross, Martin W. James, Richard Sturgess, Clive Stubbs, Deborah Stocken, Lucy Wall, Anthony Watkinson, Nigel Hacking, T.R. Jeffry Evans, Peter L. Collins, Richard Hubner, David Cunningham, John Primrose, Philip J. Johnson, Daniel H. Palmer - ˜The œLancet. Gastroenterology & hepatology 2017 cited by 497

  4. Safety and Immunogenicity of the Respiratory Syncytial Virus Vaccine RSV/ΔNS2/Δ1313/I1314L in RSV-Seronegative Children

    Authors: Ruth A. Karron, Cindy Luongo, Jocelyn San Mateo, Kimberli Wanionek, Peter L. Collins, Ursula J. Buchholz - The Journal of Infectious Diseases 2019 cited by 71

  5. A Role for Immune Complexes in Enhanced Respiratory Syncytial Virus Disease

    Authors: Fernando P. Polack, Michael N. Teng, Peter L. Collins, Gregory A. Prince, Marcus Exner, Heinz Regele, Dario D. Lirman, Richard Rabold, Scott J. Hoffman, Christopher L. Karp, Steven R. Kleeberger, Marsha Wills‐Karp, Ruth A. Karron - The Journal of Experimental Medicine 2002 cited by 398

  6. Evaluation of Recombinant Live-Attenuated Respiratory Syncytial Virus (RSV) Vaccines RSV/ΔNS2/Δ1313/I1314L and RSV/276 in RSV-Seronegative Children

    Authors: Coleen K. Cunningham, Ruth A. Karron, Petronella Muresan, Matthew S. Kelly, Elizabeth J. McFarland, Charlotte Perlowski, Jennifer Libous, Jennifer Oliva, Patrick Jean‐Philippe, Jack Moye, Elizabeth Schappell, Emily Barr, Vivian Rexroad, Benjamin Johnston, Ellen G. Chadwick, Mikhaela Cielo, Mary E. Paul, Jaime G. Deville, Mariam Aziz, Lijuan Yang, Cindy Luongo, Peter L. Collins, Ursula J. Buchholz - The Journal of Infectious Diseases 2022 cited by 50

  7. Live-Attenuated Vaccines Prevent Respiratory Syncytial Virus–associated Illness in Young Children

    Authors: Ruth A. Karron, Jessica E. Atwell, Elizabeth J. McFarland, Coleen K. Cunningham, Petronella Muresan, Charlotte Perlowski, Jennifer Libous, Stephen A. Spector, Ram Yogev, Mariam Aziz, Suzanne Woods, Kimberli Wanionek, Peter L. Collins, Ursula J. Buchholz - American Journal of Respiratory and Critical Care Medicine 2020 cited by 69

  8. Infection of Ciliated Cells by Human Parainfluenza Virus Type 3 in an In Vitro Model of Human Airway Epithelium

    Authors: Liqun Zhang, Alexander Bukreyev, Catherine Thompson, Brandy Watson, Mark E. Peeples, Peter L. Collins, Raymond J. Pickles - Journal of Virology 2004 cited by 307

  9. RSV-encoded NS2 promotes epithelial cell shedding and distal airway obstruction

    Authors: Rachael M. Liesman, Ursula J. Buchholz, Cindy Luongo, Lijuan Yang, Alan D. Proia, John P. DeVincenzo, Peter L. Collins, Raymond J. Pickles - Journal of Clinical Investigation 2014 cited by 140

  10. The M2–2 protein of human respiratory syncytial virus is a regulatory factor involved in the balance between RNA replication and transcription

    Authors: Alison Bermingham, Peter L. Collins - National Academy of Sciences, Proceedings of the National Academy of Sciences 1999 cited by 273

  11. Recombinant Human Metapneumovirus Lacking the Small Hydrophobic SH and/or Attachment G Glycoprotein: Deletion of G Yields a Promising Vaccine Candidate

    Authors: Stéphane Biacchesi, Mario H. Skiadopoulos, Lijuan Yang, Elaine W. Lamirande, Kim C. Tran, Brian R. Murphy, Peter L. Collins, Ursula J. Buchholz - Journal of Virology 2004 cited by 237

  12. Evaluation of the Live-Attenuated Intranasal Respiratory Syncytial Virus (RSV) Vaccine RSV/6120/ΔNS2/1030s in RSV-Seronegative Young Children

    Authors: Ruth A. Karron, Cindy Luongo, Suzanne Woods, Jennifer Oliva, Peter L. Collins, Ursula J. Buchholz, the RSVPed Team, Milena Gatto, Tina Ghasri, Amanda Gormley, Kristi Herbert, Maria Jordan, Karen Loehr, Jason Morsell, Jocelyn San Mateo, Elizabeth Schappell, Khadija Smith, Paula Soro, Kimberli Wanionek, Cathleen Weadon - The Journal of Infectious Diseases 2023 cited by 40

  13. Infection of Nonhuman Primates with Recombinant Human Metapneumovirus Lacking the SH, G, or M2-2 Protein Categorizes Each as a Nonessential Accessory Protein and Identifies Vaccine Candidates

    Authors: Stéphane Biacchesi, Quynh N. Pham, Mario H. Skiadopoulos, Brian R. Murphy, Peter L. Collins, Ursula J. Buchholz - Journal of Virology 2005 cited by 176

  14. Live Respiratory Syncytial Virus Attenuated by M2-2 Deletion and Stabilized Temperature Sensitivity Mutation 1030s Is a Promising Vaccine Candidate in Children

    Authors: Elizabeth J. McFarland, Ruth A. Karron, Petronella Muresan, Coleen K. Cunningham, Jennifer Libous, Charlotte Perlowski, Bhagvanji Thumar, Devasena Gnanashanmugam, Jack Moye, Elizabeth Schappell, Emily Barr, Vivian Rexroad, Laura Fearn, Stephen A. Spector, Mariam Aziz, Mikhaela Cielo, Christy Beneri, Andrew Wiznia, Cindy Luongo, Peter L. Collins, Ursula J. Buchholz - The Journal of Infectious Diseases 2019 cited by 52

  15. Taxonomy of the order Mononegavirales: update 2016

    Authors: Claudio L. Afonso, Gaya K. Amarasinghe, Krisztián Bànyai, Yīmíng Bào, Christopher F. Basler, Sina Bavari, Nicolás Bejerman, Kim R. Blasdell, François‐Xavier Briand, Thomas Briese, Alexander Bukreyev, Charles H. Calisher, Kartik Chandran, Jiāsēn Chéng, Anna N. Clawson, Peter L. Collins, Ralf G. Dietzgen, Olga Dolnik, Leslie L. Domier, Ralf Dürrwald, John M. Dye, Andrew J. Easton, Hideki Ebihara, Szilvia L. Farkas, Juliana Freitas‐Astúa, Pierre Formenty, Ron A. M. Fouchier, Yànpíng Fù, Elodie Ghedin, Michael M. Goodin, Roger Hewson, Masayuki Horie, Timothy H. Hyndman, Dàohóng Jiāng, Elliot Watanabe Kitajima, Gary Kobinger, Hideki Kondō, Gael Kurath, Robert A. Lamb, S. L. Lenardon, Eric M. Leroy, Cixiu Li, Xian-Dan Lin, Lìjiāng Liú, Ben Longdon, Szilvia Marton, Andrea Maisner, Elke Mühlberger, Netesov Sv, Norbert Nowotny, Jean L. Patterson, Susan Payne, Janusz T. Pawęska, Rick E. Randall, Bertus K. Rima, Paul Rota, Dennis Rubbenstroth, Martin Schwemmle, Mǎng Shī, Sophie J. Smither, Mark D. Stenglein, David M. Stone, Ayato Takada, Calogero Terregino, Robert B. Tesh, Jun-Hua Tian, Keizō Tomonaga, Noël Tordo, Jonathan S. Towner, Nikos Vasilakis, M. Verbeek, Viktor E. Volchkov, Victoria Wahl‐Jensen, John A. Walsh, Peter J. Walker, David Wang, Lin‐Fa Wang, Thierry Wetzel, Anna E. Whitfield, Jiǎtāo Xiè, Kwok‐Yung Yuen, Yǒng-Zhèn Zhāng, Jens H. Kuhn - Archives of Virology 2016 cited by 506

  16. Live-Attenuated Respiratory Syncytial Virus Vaccine With M2-2 Deletion and With Small Hydrophobic Noncoding Region Is Highly Immunogenic in Children

    Authors: Elizabeth J. McFarland, Ruth A. Karron, Petronella Muresan, Coleen K. Cunningham, Charlotte Perlowski, Jennifer Libous, Jennifer Oliva, Patrick Jean‐Philippe, Jack Moye, Elizabeth Schappell, Emily Barr, Vivian Rexroad, Laura Fearn, Mikhaela Cielo, Andrew Wiznia, Jaime G. Deville, Lijuan Yang, Cindy Luongo, Peter L. Collins, Ursula J. Buchholz - The Journal of Infectious Diseases 2020 cited by 57

  17. Progress in understanding and controlling respiratory syncytial virus: Still crazy after all these years

    Authors: Peter L. Collins, José A. Melero - Virus Research 2011 cited by 446

  18. Transcription elongation factor of respiratory syncytial virus, a nonsegmented negative-strand RNA virus.

    Authors: Peter L. Collins, M G Hill, Juan Cristina, Haim Grosfeld - National Academy of Sciences, Proceedings of the National Academy of Sciences 1996 cited by 298

  19. Genetic diversity between human metapneumovirus subgroups

    Authors: Stéphane Biacchesi, Mario H. Skiadopoulos, Guy Boivin, Christopher T. Hanson, Brian R. Murphy, Peter L. Collins, Ursula J. Buchholz - Virology 2003 cited by 267

  20. CFTR Delivery to 25% of Surface Epithelial Cells Restores Normal Rates of Mucus Transport to Human Cystic Fibrosis Airway Epithelium

    Authors: Liqun Zhang, Brian Button, Sherif E. Gabriel, Susan E. Burkett, Yu Yan, Mario H. Skiadopoulos, Yan L. Dang, Leatrice Vogel, Tristan R. McKay, April Mengos, Richard C. Boucher, Peter L. Collins, Raymond J. Pickles - PLoS Biology 2009 cited by 192

  21. The Secreted Form of Respiratory Syncytial Virus G Glycoprotein Helps the Virus Evade Antibody-Mediated Restriction of Replication by Acting as an Antigen Decoy and through Effects on Fc Receptor-Bearing Leukocytes

    Authors: Alexander Bukreyev, Lijuan Yang, Jens Fricke, Lily Cheng, Jerrold M. Ward, Brian R. Murphy, Peter L. Collins - Journal of Virology 2008 cited by 182

  22. Viral and Host Factors in Human Respiratory Syncytial Virus Pathogenesis

    Authors: Peter L. Collins, Barney S. Graham - Journal of Virology 2007 cited by 481

  23. Suppression of the Induction of Alpha, Beta, and Gamma Interferons by the NS1 and NS2 Proteins of Human Respiratory Syncytial Virus in Human Epithelial Cells and Macrophages

    Authors: Kirsten Spann, Kim-C. Tran, Bo Chi, Ronald L. Rabin, Peter L. Collins - Journal of Virology 2004 cited by 444

  24. Identification of a Recombinant Live Attenuated Respiratory Syncytial Virus Vaccine Candidate That Is Highly Attenuated in Infants

    Authors: Ruth A. Karron, Peter F. Wright, Robert B. Belshe, Bhagvanji Thumar, Roberta Casey, Frances Newman, Fernando P. Polack, Valerie B. Randolph, Anne M. Deatly, Jill Hackell, William C. Gruber, Brian R. Murphy, Peter L. Collins - The Journal of Infectious Diseases 2005 cited by 285